Medication may stop drug and alcohol addiction

June 23, 2015, University of Texas at Austin
Hitoshi Morikawa and his team have discovered that an FDA-approved antihypertensive drug can stop cocaine or alcohol addiction in rats. Credit: University of Texas at Austin

Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. If the treatment is proven effective in humans, it would be the first of its kind—one that could help prevent relapses by erasing the unconscious memories that underlie addiction.

The research is published this week in the journal Molecular Psychiatry.

Scientists once believed that drug was simply a physical craving: Drug addicts who became sober and then later relapsed merely lacked willpower. But that view has gradually shifted since the 1970s.

Today, most experts acknowledge that environmental cues—the people, places, sights and sounds an addict experiences leading up to drug use—are among the primary triggers of relapses. It was an environmental cue (a ringing bell) that caused the dogs in Ivan Pavlov's famous experiments to salivate, even when they couldn't see or smell food.

Led by Hitoshi Morikawa, associate professor of neuroscience at The University of Texas at Austin, a team of researchers trained rats to associate either a black or white room with the use of a drug. Subsequently, when the addicted rats were offered the choice of going into either room, they nearly always chose the room they associated with their addiction.

Then one day, the researchers gave the addicted rats a high dose of an antihypertensive drug called isradipine before the rats made their choices. Although rats still preferred the room they associated with their addiction on that day, they no longer showed a preference for it on subsequent days. In fact, the lack of preference persisted in the isradipine-treated group in ways that couldn't be found in a control group—suggesting the addiction memories were not just suppressed but had gone away entirely.

"The isradipine erased memories that led them to associate a certain room with cocaine or alcohol," said Morikawa.

Addictive drugs are thought to rewire brain circuits involved in reward learning, forming powerful memories of drug-related cues. Antihypertensive drugs all block a particular type of ion channel, which is expressed not only in heart and blood vessels but also in certain brain cells. The researchers found that blocking these ion channels in brain cells, using isradipine, appears to reverse the rewiring that underlies memories of addiction-associated places.

There are already medications that have been shown to prevent people from feeling euphoria when they take an addictive drug and that might prevent them from developing an addiction. A treatment based on this latest research, however, would be much more effective, said Morikawa, targeting the associations an addict has with the experience leading up to taking a drug.

"Addicts show up to the rehab center already addicted," he said. "Many addicts want to quit, but their brains are already conditioned. This might help the addicted brain become de-addicted."

Morikawa noted that because isradipine is already labeled as safe for human use by the FDA, clinical trials could potentially be carried out much more quickly than with nonapproved drugs.

One challenge with using isradipine in high doses to treat addiction is that it lowers blood pressure. So it might be necessary to pair it with other treatments that prevent from falling too low.

Explore further: Serotonin makes some people more susceptible to drug dependence than others

More information: "L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory," Molecular Psychiatry (June 23, 2015):

Related Stories

Serotonin makes some people more susceptible to drug dependence than others

December 5, 2014
A study by Sarah Bradbury, who graduates with a PhD in Psychology next week, shows that the development of drug addiction is related to brain levels of serotonin—a chemical created by the human body that is responsible ...

Paradigm shift in treatment of addiction holds promise, thanks to epigenetics

May 26, 2015
One of the major challenges of cocaine addiction is the high rate of relapse after periods of withdrawal and abstinence. But new research reveals that changes in our DNA during drug withdrawal may offer promising ways of ...

Researchers see way cocaine hijacks memory

March 10, 2015
Washington State University researchers have found a mechanism in the brain that facilitates the pathologically powerful role of memory in drug addiction. Their discovery opens a new area of research for targeted therapy ...

Discovery of new neural pathway may lead to preventing relapses in addicts

June 18, 2015
Researchers at the University at Buffalo have discovered a previously unknown neural pathway that can regulate changes made in the brain due to cocaine use, providing new insight into the molecular basis of cocaine addiction. ...

Alcohol helps the brain remember, says new study

April 12, 2011
Drinking alcohol primes certain areas of our brain to learn and remember better, says a new study from the Waggoner Center for Alcohol and Addiction Research at The University of Texas at Austin.

Cocaine changes the brain and makes relapse more common in addicts

April 28, 2015
Cocaine use causes 'profound changes' in the brain that lead to an increased risk of relapse due to stress - according to new research from the University of East Anglia.

Recommended for you

Study with infants suggests language not necessary for reasoning ability

March 16, 2018
A team of researchers from Spain, Hungary and Poland has found via a study with infants that language may not be a necessity for the ability to reason. In their paper published in the journal Science, the group describes ...

Hep C compounds alcoholism's effect on brain volume

March 16, 2018
(HealthDay)—Alcohol dependence has deleterious effects on frontal cortical volumes that are compounded by hepatitis C virus (HCV) infection and drug dependence, according to a study published online March 14 in JAMA Psychiatry.

Older adults' difficulties with focusing can be used to help put a face to a name

March 16, 2018
Everyone has experienced the awkward situation of meeting someone and then forgetting their name shortly after. Among older adults, this happens more often than not.

Study casts doubt on ketamine nasal sprays for depression

March 16, 2018
Researchers from the Black Dog Institute and UNSW Sydney have questioned the efficacy and safety of intranasal ketamine for depression, with their pilot trial stopped early due to poor side effects in patients.

A little anger in negotiation pays

March 16, 2018
During negotiations, high-intensity anger elicits smaller concessions than moderate-intensity anger, according to a new study by management and business experts at Rice University and Northwestern University.

Research reveals brain mechanism involved in language learning

March 15, 2018
Learning a new language may be more of a science than an art, a University of Sussex study finds.


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jun 23, 2015
We have all been here before. We have all been here before.
5 / 5 (1) Jun 23, 2015
Isradipine is a calcium channel blocker. If memory erasure is a class effect -- what are the implications for the use of calcium channel blockers in the elderly? Is there an association between their use and Alzheimer's or normal cognitive decline with aging? Calcium channel blockers are well known to moderate mood swings and are sometimes prescribed for bipolar patients. Thus they are known to be psychoactive. The research presented in this press release needs to be followed up.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.